Results published today in the prestigious Journal of Allergy and Clinical Immunology (JACI) announce a ground-breaking increase in adherence with asthma medications for patients provided with a novel device called the Smartinhaler, manufactured by digital health company Nexus6 Ltd.
Read more about Nexus6’s Smartinhaler Dramatically Improves Medication Adherence
SeaDragon Limited (SeaDragon), Australasia’s largest refiner and blender of high-quality internationally certified concentrated fish oils and fractions has appointed pharmaceutical and food industry expert Patrick Geals as a Non-Executive Independent Director.
Read more about SeaDragon Appoints Independent Director – Patrick Geals
Rex Bionics plc (AIM: RXB), the developer and manufacturer of REX products: hands-free robotic exoskeletons for use by wheelchair users, announces that it will be exhibiting at the 7th Hamlyn Symposium on Medical Robots, at the Royal Geographical Society, London, from July 13th to July 15th 2014.
Read more about REX to exhibit at the Hamlyn Symposium on Medical Robots
MELBOURNE, Australia – June 05, 2014 – Nexvet Biopharma, a leading veterinary biologic drug developer, today announced the oral presentation of data related to clinical development of NV-01, a …
AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election to the Board along with AmpliPhi’s other Class 2 directors at the Company’s Annual Meeting on June 27, 2014.
Read more about AmpliPhi Announces Appointment of New Board Member